Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Immunoglobulin Light-chain Amyloidosis × Thalidomide × Clear all

Phase

Phase 2 3 Phase 4 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Waldenstrom Macroglobulinemia 1 Stomach Neoplasms 1 Neoplasms, Second Primary 1 Neoplasms 1 NSCLC 1 Multiple Myeloma 1 Lymphoma, Mantle-Cell 1 Immunoglobulin Light-chain Amyloidosis 1

Interventions

Thalidomide 1 Cyclophosphamide 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04612582 2020-11-03

Comparison of BTD and BCD Based Regimens in the Treatment of AL Amyloidosis

Guangdong Provincial People's Hospital

Phase 4 Unknown

Immunoglobulin Light-chain Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡